 |
|
Controlling HypertensionA Research Success Story
Harriet P. Dustan, MD;
Edward J. Roccella, PhD, MPH;
Howard H. Garrison, PhD
Arch Intern Med. 1996;156(17):1926-1935.
Abstract
In the past 2 decades, deaths from stroke have decreased by 59% and deaths from heart attack by 53%. An important component of this dramatic change has been the increased use of antihypertensive drugs. This remarkable success resulted from broad-based and diverse research programs supported by the federal government, pharmaceutical companies, voluntary health agencies, and private foundations. It included basic research, drug development programs, epidemiologic studies, health surveys of US citizens, clinical research, and large-scale drug trials. Four of the categories of antihypertensive drugs in wide use—diuretics, β-blockers, calcium antagonists, and angiotensin-converting enzyme inhibitors—emerged from widely different areas of investigation. In the beginning, the major breakthroughs that led to the development of these drugs were impossible to forecast, and their ultimate applications were impossible to predict. Although decreases in hypertensionrelated mortality are impressive, enthusiasm must be tempered because the mechanisms of hypertension are still incompletely understood and prevention is not yet possible. Continued research is needed to extend these advances.
Arch Intern Med. 1996;156:1926-1935
Author Affiliations
From the Departments of Pharmacology and Medicine, University of Vermont College of Medicine, Burlington (Dr Dustan); National High Blood Pressure Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Dr Roccella); and Office of Public Affairs, Federation of American Societies for Experimental Biology, Bethesda (Dr Garrison).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Diagnosis and Treatment of Renovascular Hypertension: A Cost-Benefit Analysis
Bolduc et al.
Am. J. Roentgenol. 2005;184:931-937.
ABSTRACT
| FULL TEXT
FROM VIPER'S VENOM TO DRUG DESIGN: TREATING HYPERTENSION
Patlak
FASEB J. 2004;18:421e-421.
FULL TEXT
The National High Blood Pressure Education Program: Thirty Years and Counting
Jones and Hall
Hypertension 2002;39:941-942.
FULL TEXT
Treatment of Perioperative Hypertension in the Ambulatory Plastic Surgery Patient
Higgins
Aesthetic Surgery Journal 1999;19:257-259.
ABSTRACT
| FULL TEXT
beta Adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics
Holmer et al.
Heart 1998;80:45-48.
ABSTRACT
| FULL TEXT
Opposing National Stroke Mortality Trends in Poland and for African Americans and Whites in the United States, 1968 to 1994
Massing et al.
Stroke 1998;29:1366-1372.
ABSTRACT
| FULL TEXT
|
